Officials with the American Academy of Pediatrics stress that there’s no need for alarm but they do urge that more data be collected concerning children and COVID-19 infection, and they also note that there’s still no vaccine for youngsters 5–12.
A joint report by the American Academy of Pediatrics (AAP) and the Children’s Hospital Association indicates that 243,373 children were infected with COVID-19 from September 2 to September 9, 2021. From August 26 to September 9, 2021, there was a 10% increase in reported cases for children.1 (The definition of “child” varies from state to state but in all 49 states reporting, the age starts at 0 years. The higher-end cutoff age varies and can be anywhere from 14 to 20 years.) Children represent 15.5% of all cases in the pandemic up until this point. At present, there are no vaccines for children aged 5 to 12 years.
“At this time, it appears that severe illness due to COVID-19 is uncommon among children,” the AAP stated in a press release about the study.2 “However, there is an urgent need to collect more data on longer-term impacts of the pandemic on children, including ways the virus may harm the long-term physical health of infected children, as well as its emotional and mental health effects.”
In the 11 states reporting testing, children made up from 11.1% to 21.6% of the total cumulated tests, which showed that from 4.9% to 17.8% of children tested positive. Twenty-four states reported hospitalizations, and children accounted for 1.6% to 4% of the total cumulated hospitalizations.
Pediatricians are especially keeping a close eye on multisystem inflammatory syndrome in children, or MIS-C. According to the Centers for Disease Control and Prevention (CDC), MIS-C, “is a condition[in which] different body parts can become inflamed, including the heart, lungs, kidneys, brain, skin, eyes, or gastrointestinal organs.” The CDC admits that it does not “yet know what causes MIS-C. However, many children with MIS-C had the virus that causes COVID-19 or had been around someone with COVID-19.”
Linda Spaulding, RN-BC, CIC, CHEC, CHOP, a member of Infection Control Today®’sEditorial Advisory Board, warns that it’s a mistake to underestimate the harm COVID-19 can do to younger people.
“People keep [saying], ‘Well, the young kids [will] get it. They’ll get over it. It’s no big deal.’ But that’s not the reality of it. There are many young kids that have got COVID-19 and are now dealing with what they’re calling long-haulers disorder. And that’s when they do have heart damage or they have lung damage.”
She added that the disease “can be fatal in kids.”
References:
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.